Загрузка...
Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans.
Fourteen patients with severe viral illnesses were given intravenous infusions of a modified interferon inducer, polyriboinosinic-polyribocytidylic acid-poly-L-lysine complexed with carboxymethylcellulose [poly)I:C.LC)], during a phase 1 clinical trial. The first eight patients received 0.15 to 0.30...
Сохранить в:
| Опубликовано в: : | Infect Immun |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology (ASM)
1979
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC414523/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/500189/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.25.3.831-837.1979 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|